Last reviewed · How we verify
Acute treatment of chronic rhinosinusitis with and without nasal polyps — Treatment Landscape & Competitive Intelligence
0 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer Inc. · 1 drug in Acute treatment of chronic rhinosinusitis with and without nasal polyps
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Acute treatment of chronic rhinosinusitis with and without nasal polyps:
- Acute treatment of chronic rhinosinusitis with and without nasal polyps treatment updates — RSS
- Acute treatment of chronic rhinosinusitis with and without nasal polyps treatment updates — Atom
- Acute treatment of chronic rhinosinusitis with and without nasal polyps treatment updates — JSON
Cite this brief
Drug Landscape (2026). Acute treatment of chronic rhinosinusitis with and without nasal polyps — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/acute-treatment-of-chronic-rhinosinusitis-with-and-without-nasal-polyps. Accessed 2026-06-10.
Related
- Acute treatment of chronic rhinosinusitis with and without nasal polyps full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing